A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
Janssen Research & Development, LLC
Janssen Research & Development, LLC
National Institutes of Health Clinical Center (CC)
Boehringer Ingelheim
Replimune Inc.
Pilatus Biosciences Inc
Beijing GoBroad Hospital
Second Affiliated Hospital, School of Medicine, Zhejiang University
Henry Ford Health System
University of Nebraska
Shanghai Juncell Therapeutics
IDRx Inc. - A GSK Company
Elevation Oncology
Fox Chase Cancer Center
Arbele Limited
Revolution Medicines, Inc.
Indiana University
Revolution Medicines, Inc.
NYU Langone Health
Boehringer Ingelheim
University of Utah
Revolution Medicines, Inc.
Peking University
The Netherlands Cancer Institute
Celldex Therapeutics
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Five Prime Therapeutics, Inc.
University of Rochester
University of Chicago
Jiangsu HengRui Medicine Co., Ltd.
Revolution Medicines, Inc.
Xencor, Inc.
Washington University School of Medicine
Curegenix Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Takeda
Curegenix Inc.
Virginia Commonwealth University
IGF Oncology, LLC
Institut du Cancer de Montpellier - Val d'Aurelle
University of Illinois at Chicago
National Cancer Institute (NCI)
Hangzhou Converd Co., Ltd.
Eisai Inc.
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
University of Nottingham
Hallym University Medical Center
Dana-Farber Cancer Institute